Research Article
Impact of the COVID-19 Lockdown on Ophthalmological Assistance in the Emergency Department at a Spanish Primary Level Hospital
Table 2
Diagnosis distribution of the most prevalent clusters.
| Cluster | Primary diagnosis | Secondary diagnosis | Pre-COVID-19 | Post-COVID-19 | Change (%) |
| Conjunctiva | Conjunctivitis | Allergic | 58 | 27 | −53.4 | Bacterial | 7 | 7 | 0 | Unspecific | 82 | 23 | −72 | Chemical | 5 | 2 | −60 | Viral | 116 | 15 | −87.1 | Total | 268 | 74 | −72.4 | Subconjunctival bleeding | | 58 | 20 | −65.5 | Conjunctival lymphangiectasia | | 9 | 4 | −55.6 | Pterygium/pinguecula | | 12 | 8 | +33.3 | Conjunctival traumatism | | 8 | 9 | +12.5 | Others | | 9 | 11 | +22.2 | | Total | 96 | 52 | −45.8 | Total conjunctiva | | 364 | 126 | −65.4 |
| Cornea and sclera | Corneal ulcers and keratitis | Recurrent corneal erosion | 3 | 8 | +167.7 | Actinic keratitis | 5 | 1 | −80 | Acanthamoeba keratitis | 1 | 0 | −100 | Bacterial keratitis | 13 | 3 | −76.9 | Herpetic/metaherpetic keratitis | 18 | 25 | +38.9 | Contact lens keratitis | 13 | 7 | −46.2 | Chemical keratitis | 10 | 9 | −10 | Traumatic keratitis | 37 | 26 | −29.7 | Other ulcers and keratitis | 10 | 14 | +40 | Foreign body | Corneal metallic foreign body | 36 | 28 | −22.2 | Other foreign body | 18 | 6 | −66.7 | Dry eye and dry eye related keratitis | | 98 | 48 | −51 | Corneal subepithelial infiltrates (CSEI) | | 4 | 4 | 0 | Sclera | Episcleritis | 19 | 10 | −47.4 | Others | | 25 | 10 | −60 | Total cornea and sclera | | 310 | 199 | −35.8 |
| Eyelid and orbit and lacrimal | Orbit | Preseptal cellulitis | 4 | 4 | 0 | Orbit traumatism | 6 | 1 | −83.3 | Others | 3 | 2 | −33.3 | Inflammatory palpebral disorders | Blepharitis | 57 | 35 | −38.6 | Stye/chalazion | 63 | 34 | −46 | Unspecific eyelid inflammation | 8 | 8 | 0 | Palpebral herpes | 5 | 11 | +120 | Eyelid malposition | Trichiasis/distichiasis | 22 | 20 | −9.1 | Ectropion | 2 | 1 | −50 | Entropion | 4 | 1 | −75 | Floppy eyelid | 1 | 1 | 0 | Facial palsy | 1 | 1 | 0 | Tarsal foreign body | 8 | 6 | −25 | Others | 19 | 7 | −63.2 | Lacrimal disorders | Acute dacryocystitis | 8 | 5 | −37.5 | Others | 9 | 5 | −44.4 | Total eyelid and orbit and lacrimal | | 220 | 142 | −35.5 |
| Retina | Rhegmatogenous retinal disorders | PVD | 97 | 79 | −18.6 | Photopsias (isolated) | 3 | 2 | −33.3 | Rhegmatogenous lesion | 9 | 8 | −11.1 | Retinal rhegmatogenous detachment | 10 (8/10 macula-off) | 16 (12/16 macula off) | +60 | AMD | AMD (dry) | 2 | 1 | −50 | AMD (wet) | 3 | 11 | +266.7 | CSC | 3 | 2 | −33.3 | Other macular neovascularizations | 3 | 6 | +100 | Diabetic retinopathy | Diabetic ME | 4 | 4 | 0 | Diabetic vitreous hemorrhage | 6 | 5 | −16.7 | Vascular occlusions | CRAO/BRAO | 1 | 0 | −100 | CRVO/BRVO | 10 | 10 | 0 | Others | 37 | 24 | −35.1 | Total retina | 188 | 168 | −10.6 |
|
|
PVD = posterior vitreous detachment; AMD = age related macular degeneration; CSC = central serous choroidopathy; CRAO = central retina artery occlusion; BRAO = branch retina artery occlusion; CRVO = central retina vein occlusion; BRVO = branch retina vein occlusion.
|